A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors

Completed · Not applicable

Conditions studied: Tumor, Benign, Optic Nerve

In brief

The purpose of this study is to find out what effects (good and bad) CyberKnife stereotactic radiosurgery has on tumors near the critical structures of the eye (optic apparatus). The investigators hypothesize that hypofractionated stereotactic radiotherapy via the CyberKnife ® can deliver tumor ablating doses of radiation to perioptic lesions safely and effectively while sparing the adjacent optic apparatus and normal brain tissues from receiving damaging doses of radiation.

Key facts

Study ID

NCT02225197

Run by

Community Cancer Center, Normal, Illinois

People needed

10

Starts

2007-12-01

Expected to finish

2017-10-01

Last updated by the study team

2019-07-25

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Perioptic lesion within 2mm of the optic apparatus
• Age >= 21
• KPS >= 50
• Planning Target Volume (PTV) <= 6.0 cm in maximal diameter

You may not qualify if…

• Malignant histology
• Age < 21
• KPS <= 40
• Planning Target Volume (PTV) > 6.0 cm in maximal diameter
• Prior whole brain XRT
• Gross total resection

Where it is running

• Community Cancer Center — Normal, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.